NuBax_description

7/30/2019 NuBax_description

1/8

Why Nubax ?

Nubaxpresentsa uniqueopportunityto provide aquality health

care product worldwide andaddress the ever growingproblem o chronic back pain

throughout the World.

Through its very simple, yet eective patented

invention, Nubax provides an opportunity or

companies engaged in the delivery o health care

and therapeutic goods to advance their presence in

a market which generates billions o dollars each and

every year.

The Nubax Trio is simple to use, portable, accessible

and is now clinically proven as a orm o eective drug

ree therapy or the management o chronic back pain.

Nubax provides considerable benets or back

pain suerers, health providers, health insurers and

distributors o therapeutic devices.


2/8

The Nubax Trios unique leveraction utilises the users ownbodyweight to apply tractionto the spine while the body isheld in correct alignment at theshoulders and hips.The technology or the Nubax Trio was initially

developed in Australia by Richard Miller and was

patented in Australia in 1992.

Nubax is owned by R & R Therapeutic Pty Ltd; a

company incorporated in Western Australia. Well in

excess o A$2 million has been spent on product and

market development to date.

Until the Nubax Trio was launched in 1999, traction

devices were either clinical installations that cost many

thousands o dollars, or crudely unctioning devices

including those that require the user to hang upside down!

The Nubax Trio, now with patents and

distributors worldwide, has dramatically altered

accessibility to eective and sae traction both

in the home and in a clinical setting. Nubax is

leading the ever increasing acceptance o traction

as a credible orm o treatment or a wide range

o back problems. It is easy to use, portable and

saely applies the equivalent degree o traction

orce as the most expensive clinical device.

Nubax Background


3/8

Nubax Product

The Nubax Trio enables peopleto improve their quality o lie.Not only is the Nubax Trio usedas a means o back pain relie and

prevention, it is also useul asa method o strengthening theback and improving fexibility.

It is particularly eective or people conscious o their

health, tness and vitality; as well as those who are

susceptible to or suering rom back pain.

The Nubax Trio helps to:

Relieve low back pain. Maintain a healthy back.

Strengthen the back.

Perorm physicallydemanding activity.

Maintain mobility anda healthy liestyle.

Aid the speedyrecovery rom existingconditions.

The Nubax Trio is a unctional therapeutic device that

provides traction therapy, and can be eective in:

Occupational health.

Sport.

Pain management.

Exercise.

Relaxation.

Pre-activity warm-up andpost-activity warm-down(Injury prevention).

The key benets o Nubax Trio include:

Benecial adjunct to a wide range o popularorms o therapy.

The ability or users to apply traction to the spineunder their own complete control, wherever andwhenever they need it.

Provides a credible alternative to intermittent(cyclical) traction.

Provides a gentle but strong static traction orce.

By holding the shoulders and hips in a symmetricalposition, the spine is correctly aligned during use.

Easy to use and ully portable.

Drug ree pain relie.


4/8

Since being made availableto domestic markets in 1999,Nubax has consistentlyreceived a positive responseto the product with wellover 3,500 users in Australiaalone, enjoying considerableimprovement to theirquality o lie.

In the ormative years, Nubax ocussed predominately

on the development and ecacy o the product in

order to establish credibility. However, during this

period, marketing activities directed at back pain

suerers on television and in the print media have

yielded some encouraging results

Television segments on A Current Aair in 2001

and 2007 yielded sales revenue in excess o $120,000

on both occasions, while advertisements in the Herald

Sun and other major publications have also yielded

positive returns.

As a result o this exposure, thousands o Australians

have now made the Nubax Trio part o their daily

routine.

Nubax Exposure To Markets


5/8

Nubax Customer Experience

According to the Australian

Bureau o Statistics, it is estimated

that approximately 15%

(3.1 million) o the Australian

population suer rom back

pain. The Nubax customer is

someone who wants to relieve or

prevent back pain and thereore,

improve their quality o lie.

Many Nubax Trio users, particularly those suering

some orm o unspecied lower back pain, have reported

signicant reduction in pain and dramatic improvements

to their physical movement as a result o using the

Nubax Trio.

The Nubax Trio is now being recommended and

prescribed to patients by an increasing number

o chiropractors, physiotherapists and osteopaths

throughout Australia.

Jim Stynes Melbourne Football Club

- 264 AFL games

- AFL Hall O Fame inductee

- Brownlow medallist

- 4 x Best & Fairest Winner

- 2x All Australian

My back pain was so severe thatit got to the stage where I couldntsit in a chair or more than a ewminutes. When I did sit down, the

discs would bulge, causing pressure on the nerves in my back andconsiderable pain.

Now, having used the Nubax Trio or almost our months, mysymptoms have reoccurred just once and I ound that I dont have torely on anti-inammatories anywhere near as much as I used to.


6/8

Carrying the CEdeclaration o conormity,the Nubax Trio is listed

with the Therapeutic GoodsAdministration o Australia andis also supported by scoreso healthcare providers rightacross Australia.

In 2006 clinical trials conducted and supervised by the

University o Western Australia concluded that the

Nubax Trio was an eective orm o relie or suerers

o a wide range o chronic back condition.

Peter Hamer DipPhys, BPE (Hons) MEd, FASMF and Director,Functional Rehabilitation Program

This sel-traction and relaxation device has proved useul inthe management o lower- back pain. Clients that have usedthe Nubax as part o their overall exercise rehabilitationprogram, conducted at the Clinic, have reported some relie o

discomort and an increased range o movement.

Dr G.D Cooper ChiropractorRecently, I had the opportunity o testing the Nubax Trio in aclinical setting. Random patients were chosen to try this deviceover a one-week period. Within this short trial period patientsreported that the Nubax Trio provided a good, relievingstretch to their parapineal musculature.

Dr Tim Ackland PhD Associate Proessor, Departmento Human Movement, UWAThe Nubax Trio is more eective than massage and core

stability exercises alone and its beauty lies in the act you canuse it at home or just a ew minutes a couple o times a dayto receive the benefts, he said.

Nubax Therapeutic Credentials


7/8

Success or Nubax means that

Nubax is recognised as the rst

choice or back pain suerers

looking to improve their quality

o lie; that it is endorsed and

recommended by healthcare

providers not only as a means o

pain management, but as a means

o aiding mobility; and that people

rom all walks o lie are ableto enjoy a better quality o lie

because o Nubax.

The Nubax Trio is distributed internationally through

a variety o channels to market, utilizing the values

and standards synonymous with the high quality and

ecacy o the Nubax product.

We are oering an exclusive opportunity to distribute

and/or manuacture the Nubax Trio under license.

We are also seeking partners in the uture research

and development o the Nubax product range,

including the development o condition specic

protocols o use or healthcare providers. A research

and design team will consult internationally and

work in partnership to maximise the opportunities

presented by Nubax patented technology.

Nubax Vision


8/8

Nubax is entering one othe most exciting phases in

its relatively short history.The success o the University o Western Australias

clinical trials, coupled with a stronger marketing

ocus has led to Nubax developing new distribution

channels internationally, while they continue to

eectively manage their existing channels throughout

Australia and New Zealand.

The research and

development team

has also developed

several prototypes

which will be

made available to

consumers on a

global scale in the years to come, while a number

o accessories and urther literary studies are also

currently in the development phase.

Nubax Future

Documents

NuBax_description